These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7248983)

  • 1. Phase II study of vindesine in patients with metastatic breast cancer.
    Cobleigh MA; Williams SD; Einhorn LH
    Cancer Treat Rep; 1981; 65(7-8):659-63. PubMed ID: 7248983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of vindesine in patients with advanced breast cancer.
    Walker BK; Raich PC; Fontana J; Subramanian VP; Rogers JS; Knost JA; Denning B
    Cancer Treat Rep; 1982 Sep; 66(9):1729-32. PubMed ID: 6288237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer.
    Yap HY; Blumenschein GR; Keating MJ; Hortobagyi GN; Tashima CK; Loo TL
    Cancer Treat Rep; 1980; 64(2-3):279-83. PubMed ID: 7407762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusion.
    Yap HY; Blumenschein GR; Bodey GP; Hortobagyi GN; Buzdar AU; DiStefano A
    Cancer Treat Rep; 1981; 65(9-10):775-9. PubMed ID: 7273012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vindesine for metastatic malignant melanoma. A phase II trial.
    Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vindesine: an effective agent in the treatment of non-small cell lung cancer.
    Furnas BE; Williams SD; Einhorn LH; Cobleigh MA
    Cancer Treat Rep; 1982 Sep; 66(9):1709-11. PubMed ID: 7116347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vindesine. A phase II trial in advanced breast cancer patients.
    Robins HI; Tormey DC; Skelley MJ; Falkson G; Crowley JJ; Ramirez G; Falkson H
    Cancer Clin Trials; 1981; 4(4):371-5. PubMed ID: 7318120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vindesine and adriamycin in the therapy of metastatic breast cancer].
    Wander HE; Nagel GA
    Onkologie; 1982 Aug; 5 Suppl():5-7. PubMed ID: 6752792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors.
    Miller TP; Jones SE; Chester A
    Cancer Treat Rep; 1980; 64(8-9):1001-3. PubMed ID: 7448818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study.
    Delva R; Pienkowski T; Tubiana N; Vanhoefer U; Longerey B; Douville I
    Cancer Chemother Pharmacol; 2007 May; 59(6):703-9. PubMed ID: 17021821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II evaluation of vindesine in patients with advanced breast cancer.
    Currie VE; Camacho F; Wittes R; Young C
    Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of esophageal cancer with vindesine: an open trial.
    Bezwoda WR; Derman DP; Weaving A; Nissenbaum M
    Cancer Treat Rep; 1984 May; 68(5):783-5. PubMed ID: 6722833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A cooperative phase II study of vindesine sulfate in patients with solid tumors].
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2036-42. PubMed ID: 6614938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vindesine in the treatment of metastatic breast cancer.
    Hansen PV; Brincker H
    Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1221-5. PubMed ID: 6541581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
    Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
    Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
    Klaassen U; Wilke H; Pari CP; Strumberg D; Harstrick A; Eberhardt W; Becher R; Diergarten K; Seeber S
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous 5-day infusion of vinblastine for percutaneous hepatic arterial chemotherapy for metastatic breast cancer.
    Fraschini G; Fleishman G; Charnsangavej C; Carrasco CH; Hortobagyi GN
    Cancer Treat Rep; 1987 Nov; 71(11):1001-5. PubMed ID: 3677109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.